Home / Filers / abrdn Healthcare Opportunities Fund
abrdn Healthcare Opportunities Fund
fund voting report
- Vote records reported
- 708year to 30 June 2026
- Against management
- 23.3%165 of 708 marked votes
- Say-on-pay support
- 32.8%for, of for + against + abstain
- Shareholder-proposal support
- 37.5%for, of for + against + abstain
foragainstabstain, withhold or otheramber tick: the portion cast against management
For the year to 30 June 2026, abrdn Healthcare Opportunities Fund reported 708 vote records on Form N-PX. 165 of the 708 votes that were marked for or against management went against management: 23.3%, 17.1 percentage points above the median fund registrant (6.2%).
Weighted by the number of shares voted, the against-management share is 21.8%. The two figures differ when the votes against management fall on larger or smaller holdings than the rest.
On pay and on shareholder proposals: it voted for 32.8% of the section 14A say-on-pay items it reported (the median fund registrant: 91.6%) and it voted for 37.5% of the proposals put forward by security holders (the median fund registrant: 27.5%).
By category, votes against management were most frequent in SECTION 14A SAY-ON-PAY VOTES (60.3% of 68), CAPITAL STRUCTURE (42.9% of 28) and AUDIT-RELATED (39.7% of 63).
Compared with other filers
Each rate is defined once, in the methodology. The median is taken over 1,241 fund registrants with at least 25 vote records in the season.
| year to 30 June 2026 | This filer | Median fund registrant | All filers pooled |
|---|---|---|---|
| Against-management share | 23.3% | 6.2% | 10.6% |
| Say-on-pay support rate | 32.8% | 91.6% | 86.0% |
| Shareholder-proposal support rate | 37.5% | 27.5% | 33.9% |
| Shares on loan, share of shares held | 0.00% | 0.00% | 3.12% |
| Largest families, year to 30 June 2026 | Against management | Say-on-pay support | Shareholder-proposal support |
|---|---|---|---|
| Vanguard | 20.1% | 94.1% | 42.0% |
| BlackRock and iShares | 7.5% | 88.3% | 11.9% |
| Fidelity | 6.0% | 94.7% | 27.6% |
| Dimensional | 16.4% | 78.9% | 57.4% |
| State Street and SPDR | 16.9% | 77.1% | 50.4% |
Votes by category
Filers choose one or more categories for each vote, so a vote can appear in more than one row. Category names are printed as Form N-PX defines them.
| Category (as the form names it) | Votes | For | Against | Against management | Split |
|---|---|---|---|---|---|
| DIRECTOR ELECTIONS | 462 | 393 | 41 | 14.9% | |
| SECTION 14A SAY-ON-PAY VOTES | 68 | 20 | 41 | 60.3% | |
| AUDIT-RELATED | 63 | 38 | 25 | 39.7% | |
| SHAREHOLDER RIGHTS AND DEFENSES | 4 | 4 | 0 | 0.0% | |
| CAPITAL STRUCTURE | 28 | 16 | 12 | 42.9% | |
| COMPENSATION | 43 | 33 | 10 | 25.6% | |
| CORPORATE GOVERNANCE | 39 | 33 | 6 | 17.9% | |
| ENVIRONMENT OR CLIMATE | 2 | 0 | 2 | 0.0% | |
| DIVERSITY, EQUITY, AND INCLUSION | 2 | 0 | 2 | 0.0% | |
| OTHER SOCIAL ISSUES | 6 | 0 | 6 | 0.0% |
By season
| Season | Vote records | Against management | Say-on-pay support | Shareholder-proposal support | Split |
|---|---|---|---|---|---|
| year to 30 June 2024 | 920 | 18.4% | 29.4% | 44.2% | |
| year to 30 June 2025 | 742 | 20.3% | 25.0% | 32.4% | |
| year to 30 June 2026 | 708 | 23.3% | 32.8% | 37.5% |
Say-on-pay votes against management
Counting one say-on-pay item per company meeting, abrdn Healthcare Opportunities Fund voted against management on 40 of the 60 it marked either way (66.7%) in the year to 30 June 2026.
- AbbVie Inc. 8 May 2026
- Merck & Co., Inc. 26 May 2026
- UnitedHealth Group Incorporated 1 Jun 2026
- Thermo Fisher Scientific Inc. 20 May 2026
- Abbott Laboratories 24 Apr 2026
- Bristol-Myers Squibb Company 5 May 2026
- Danaher Corporation 5 May 2026
- Intuitive Surgical, Inc. 30 Apr 2026
- MEDTRONIC PLC 16 Oct 2025
- Stryker Corporation 6 May 2026
- CVS Health Corporation 14 May 2026
- Boston Scientific Corporation 30 Apr 2026
- Zoetis Inc. 20 May 2026
- GE HEALTHCARE TECHNOLOGIES INC. 7 May 2026
- McKesson Corporation 30 Jul 2025
- Becton, Dickinson and Company 27 Jan 2026
- Elevance Health, Inc. 13 May 2026
- Welltower Inc. 21 May 2026
- HCA Healthcare, Inc. 23 Apr 2026
- IQVIA Holdings Inc. 23 Apr 2026
- DexCom, Inc. 27 May 2026
- ResMed Inc. 19 Nov 2025
- Humana Inc. 16 Apr 2026
- Insulet Corporation 20 May 2026
- Healthpeak Properties, Inc. 30 Apr 2026
- Tenet Healthcare Corporation 27 May 2026
- Repligen Corporation 14 May 2026
- Molina Healthcare, Inc. 6 May 2026
- Sabra Health Care REIT, Inc. 17 Jun 2026
- Vericel Corporation 29 Apr 2026
- Sarepta Therapeutics, Inc. 4 Jun 2026
- Acadia Healthcare Company, Inc. 6 May 2026
- LTC Properties, Inc. 20 May 2026
- Tandem Diabetes Care, Inc. 20 May 2026
- NeoGenomics, Inc. 21 May 2026
- Arcus Biosciences, Inc. 11 Jun 2026
- Diversified Healthcare Trust 10 Jun 2026
- Myriad Genetics, Inc. 4 Jun 2026
- ARS Pharmaceuticals, Inc. 24 Jun 2026
- Abivax SA 11 May 2026
Shareholder proposals it supported
Of 16 proposals from security holders that could be told apart in the filings and on which it cast a vote, abrdn Healthcare Opportunities Fund voted for 6 (37.5%). Titles are the most common wording among filers; where a wording could name a person, the SEC category is printed instead.
| Company | Meeting | Proposal |
|---|---|---|
| Eli Lilly and Company | 4 May 2026 | Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. |
| AbbVie Inc. | 8 May 2026 | Stockholder Proposal - to Adopt a Policy to Require an Independent Chair |
| Bristol-Myers Squibb Company | 5 May 2026 | Require Independent Board Chair |
| Boston Scientific Corporation | 30 Apr 2026 | Stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting." |
| IQVIA Holdings Inc. | 23 Apr 2026 | If properly presented, a stockholder proposal concerning separate Chairman and Chief Executive Officer roles. |
| Humana Inc. | 16 Apr 2026 | The stockholder proposal requesting shareholder approval requirement for excessive golden parachutes |
Shares on loan
abrdn Healthcare Opportunities Fund reported no shares on loan for the year to 30 June 2026. Shares lent out at the record date cannot be voted by the lender, which is why Form N-PX asks for the figure. More on lending and votes.
The filings
These figures are read from the filer's own Form N-PX. If a vote on this page looks wrong, the filing is the record: a dispute about a filed vote is a matter for the filer, and an error in how this site read the filing is a matter for corrections.
- N-PX filed 21 Aug 2026 accession 0001104659-26-099472
- Every N-PX filing by this filer on EDGAR
Questions
How did abrdn Healthcare Opportunities Fund vote on executive pay?
In the year to 30 June 2026 abrdn Healthcare Opportunities Fund reported 61 votes in the category SECTION 14A SAY-ON-PAY VOTES that were cast for, against or abstain. 20 were for (32.8%), 41 against and 0 abstentions. Counting one item per company meeting, it voted against management on 40 of the 60 say-on-pay items it marked either way.
How often does abrdn Healthcare Opportunities Fund vote against management?
23.3% of the time in the year to 30 June 2026: 165 of the 708 votes it marked as for or against management. Form N-PX asks each filer to state, vote by vote, whether the vote was for or against management's recommendation; this figure counts those marks.
Did abrdn Healthcare Opportunities Fund support shareholder proposals on climate?
In the category ENVIRONMENT OR CLIMATE it reported 2 votes on proposals from security holders in the year to 30 June 2026 and voted for 0 of them (0.0%). Across every category it voted for 37.5% of security-holder proposals. Filers choose the category for each vote, so the same proposal can sit in different categories in different filings.
Is this the result of the meetings?
No. Form N-PX shows how this filer voted the shares it held. It does not show how other shareholders voted or whether a proposal was approved. Companies report certified results separately, on Form 8-K.
Where does the data come from?
From the Form N-PX filings of this filer on the SEC's EDGAR system, read as filed. The SEC does not verify the contents. Amended filings (N-PX/A) replace the filings they amend. Data on this page runs through 23 Sep 2026.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings by abrdn Healthcare Opportunities Fund (filer no. 1604522), read as filed and not verified by the SEC. Amended filings replace the filings they amend. Filings read through 23 Sep 2026; page built 26 Sep 2026.